Cartesian Therapeutics Inc (RNAC)
15.77
-8.50
(-35.02%)
USD |
NASDAQ |
Jul 02, 16:00
15.89
+0.12
(+0.76%)
Pre-Market: 08:28
Cartesian Therapeutics Free Cash Flow: -58.99M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -58.99M |
| December 31, 2023 | -51.37M |
| September 30, 2023 | -40.08M |
| June 30, 2023 | -26.94M |
| March 31, 2023 | -29.41M |
| December 31, 2022 | -32.83M |
| September 30, 2022 | -52.51M |
| June 30, 2022 | -67.34M |
| March 31, 2022 | -61.63M |
| December 31, 2021 | -61.47M |
| September 30, 2021 | -37.17M |
| June 30, 2021 | 39.09M |
| March 31, 2021 | 33.74M |
| December 31, 2020 | 34.07M |
| September 30, 2020 | 28.59M |
| June 30, 2020 | -47.88M |
| March 31, 2020 | -43.08M |
| Date | Value |
|---|---|
| December 31, 2019 | -51.48M |
| September 30, 2019 | -51.68M |
| June 30, 2019 | -56.65M |
| March 31, 2019 | -66.68M |
| December 31, 2018 | -60.04M |
| September 30, 2018 | -59.74M |
| June 30, 2018 | -59.21M |
| March 31, 2018 | -50.99M |
| December 31, 2017 | -52.76M |
| September 30, 2017 | -38.58M |
| June 30, 2017 | -28.76M |
| March 31, 2017 | -25.41M |
| December 31, 2016 | -20.34M |
| September 30, 2016 | -29.49M |
| June 30, 2016 | -29.84M |
| March 31, 2016 | -28.91M |
| December 31, 2015 | -23.63M |
Free Cash Flow Range, Past 5 Years
-67.34M
Minimum
Jun 2022
39.09M
Maximum
Jun 2021
-30.44M
Average
-43.08M
Median
Mar 2020
Free Cash Flow Benchmarks
| Marinus Pharmaceuticals Inc | -113.98M |
| Adial Pharmaceuticals Inc | -6.134M |
| Poseida Therapeutics Inc | -71.71M |
| Viracta Therapeutics Inc | -36.40M |
| Biomea Fusion Inc | -105.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.92M |
| Cash from Investing (Quarterly) | -0.602M |
| Cash from Financing (Quarterly) | 43.03M |
| Free Cash Flow Per Share (Quarterly) | -3.051 |
| Free Cash Flow to Equity (Quarterly) | -16.52M |
| Free Cash Flow Yield | -71.31% |